Viramune (nevirapine) is a small molecule pharmaceutical. Nevirapine was first approved as Viramune on 1996-06-21. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. Viramune's patent is valid until 2029-03-12 (FDA).
|Indication||acquired immunodeficiency syndrome, hiv infections|
|Drug Class||Tricyclic compounds; antivirals|